GlassScriptPhysician profile
Kayla Magee Bryson
NPI 1114614922
$741.34
in general payments reported to CMS, 2019-2025
9 companies · $636 in 2025
The $636 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $105 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $741.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $178.52 | 2024-2025 | Movantik |
| Saluda Medical Americas, INC. | $174.71 | 2025 | Evoke |
| Boston Scientific Corporation | $122.35 | 2024-2025 | General - Pain Management |
| Scilex Pharmaceuticals INC. | $85.79 | 2025 | |
| Abbvie INC. | $54.82 | 2025 | |
| Virtus Pharmaceuticals LLC | $42.12 | 2025 | Levorphanol Tartrate |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.73 | 2025 | Relistor |
| Nalu Medical, INC. | $29.11 | 2024 | Nalu Neurostimulation System |
| Pfizer INC. | $16.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Bryson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.